Mayo Clinic Proceedings. Digital health最新文献

{"title":"Natural Language Processing for Enhanced Clinical Decision Support in Allergy Verification for Medication Prescriptions","authors":"Juan Pablo Botero-Aguirre MS ,&nbsp;Michael Andrés García-Rivera MS","doi":"10.1016/j.mcpdig.2025.100244","DOIUrl":"10.1016/j.mcpdig.2025.100244","url":null,"abstract":"<div><h3>Objective</h3><div>To develop and validate a named entity recognition (NER) model based on BERT-based model trained on Spanish-language corpor, for extracting allergy-related information from unstructured electronic health records.</div></div><div><h3>Patients and Methods</h3><div>The model was fine-tuned using 16,176 manually annotated allergy-related entities from anonimized patient records (hospitalized patients between January 1, 2021, and June 30, 2024). The data set was divided into training (80%) and testing (20%) subsets, and model performance was evaluated using accuracy, recall, and F1 score. The validated model was applied to another data set with 80,917 medication prescriptions from 5859 hospitalized patients with at least one prescribed medication (during August and September 2024) to detect potential prescription errors. Sensitivity, specificity, and Cohen κ were calculated using manual expert review as the gold standard.</div></div><div><h3>Results</h3><div>The model achieved an accuracy of 87.28% and an F1 score of 0.80. It effectively identified medication names (F1=0.91) and adverse reactions (F1=0.85) but struggled with recommendation-related entities (F1=0.29). The model detected prescription errors in 0.96% of cases, with a sensitivity of 75.73% and specificity of 99.98%. The weighted κ score (0.7797) indicated substantial agreement with expert annotations.</div></div><div><h3>Conclusion</h3><div>The BERT-based model trained on Spanish-language corpora–based NER model demonstrated strong performance in identifying nonallergic cases (specificity, 99.98%; negative predictive value, 99.97%) and showed promise for clinical decision support. Despite moderate sensitivity (75.73%), these results highlight the feasibility of using Spanish-language NER models to enhance medication safety.</div></div>","PeriodicalId":74127,"journal":{"name":"Mayo Clinic Proceedings. Digital health","volume":"3 3","pages":"Article 100244"},"PeriodicalIF":0.0,"publicationDate":"2025-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144571685","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Reliability of Cycle Applications for Pregnancy Planning and Contraception: A Systematic Review","authors":"Isabell Rabe DMD, MPH ,&nbsp;Jan P. Ehlers DVM, MA","doi":"10.1016/j.mcpdig.2025.100239","DOIUrl":"10.1016/j.mcpdig.2025.100239","url":null,"abstract":"<div><h3>Objective</h3><div>To show the effectiveness of cycle applications in both areas of application—contraception and intended pregnancy.</div></div><div><h3>Methods</h3><div>A systematic review based on the PubMed and Google Scholar databases, with the addition of a hand search, was conducted from May 11, 2023, through April 11, 2024, to objectively answer this question. Of 1539 sources with matching search terms, 19 sources remained after checking for inclusion criteria according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses scheme. These were analyzed according to an evaluation scale regarding their quality in various areas. The average quality ratings and pregnancy probabilities of the studies were compared.</div></div><div><h3>Results</h3><div>Comparability within and between the subquestions was hardly possible owing to different presentation of results, bias risks, and mostly uncontrolled study designs. Applications for those wishing to become pregnant provided better quality ratings in some cases. There were indications that cycle applications shorten the time to achieving a desired pregnancy in cases of reduced fertility. In addition, some seem to have a similar contraceptive safety as the contraceptive pill but require significantly more compliance.</div></div><div><h3>Conclusion</h3><div>Independent, controlled studies with a diverse clientele of test subjects are necessary for a scientific classification. In addition, social, structural, and political adjustments are needed to enable individuals to make informed decisions about the use of cycle and fertility applications.</div></div>","PeriodicalId":74127,"journal":{"name":"Mayo Clinic Proceedings. Digital health","volume":"3 4","pages":"Article 100239"},"PeriodicalIF":0.0,"publicationDate":"2025-06-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145109430","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Medication Adherence Technologies: A Classification Taxonomy Based on Features","authors":"Bincy Baby PharmD, MSc ,&nbsp;Jasdeep Kaur Gill PharmD ,&nbsp;Sadaf Faisal BPharm, PhD ,&nbsp;Ghada Elba PharmD, MSc ,&nbsp;SooMin Park PharmD (c) ,&nbsp;Annette McKinnon ,&nbsp;Kirk Patterson BA ,&nbsp;Sara J.T. Guilcher PT, PhD ,&nbsp;Feng Chang PharmD ,&nbsp;Linda Lee MD ,&nbsp;Catherine Burns PhD ,&nbsp;Ryan Griffin PhD ,&nbsp;Tejal Patel BScPharm, PharmD","doi":"10.1016/j.mcpdig.2025.100237","DOIUrl":"10.1016/j.mcpdig.2025.100237","url":null,"abstract":"<div><h3>Objective</h3><div>To develop a comprehensive classification system for medication adherence technologies based on an inventory of characteristics and features of existing technology.</div></div><div><h3>Participants and Methods</h3><div>Using a 3-stage approach methodology—development, validation, and evaluation, the study adopted the taxonomy development method and was conducted from February 1, 2023 to July 31, 2024. In the development stage, medication adherence technologies were defined, end users were identified, and a meta-characteristic was determined; using both empirical-to-conceptual and conceptual-to-empirical approaches, dimensions and characteristics were identified. The taxonomy was validated through the Delphi consensus approach and classifying 20 sample medication adherence technologies and evaluated by mapping to codes identified from a qualitative study.</div></div><div><h3>Results</h3><div>After undergoing 8 iterations, which included incorporating feedback from a Delphi consensus survey, the final taxonomy comprised 7 dimensions, 25 subdimensions, and 320 characteristics. These key dimensions include Physical Features, Display, Connectivity, System Alert, Data Collection and Management, Operations, and Integration. The taxonomy was considered complete and valuable once all preestablished ending conditions were met, and its applicability and comprehensiveness were verified by comparing various medication adherence technologies and mapping to codes identified from a qualitative study.</div></div><div><h3>Conclusion</h3><div>This study successfully establishes the first comprehensive classification system for medication adherence technologies based on features, addressing a critical gap in literature. The taxonomy provides a structured framework for categorizing and evaluating technologies, supporting usability testing and the selection of appropriate devices tailored to the unique needs of older adults.</div></div>","PeriodicalId":74127,"journal":{"name":"Mayo Clinic Proceedings. Digital health","volume":"3 3","pages":"Article 100237"},"PeriodicalIF":0.0,"publicationDate":"2025-06-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144596753","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Development and Evaluation of an Artificial Intelligence–Powered Surgical Oral Examination Simulator: A Pilot Study","authors":"Arya S. Rao BA ,&nbsp;Siona Prasad BA ,&nbsp;Richard S. Lee BS ,&nbsp;Susan Farrell MD ,&nbsp;Sophia McKinley MD, MED ,&nbsp;Marc D. Succi MD","doi":"10.1016/j.mcpdig.2025.100241","DOIUrl":"10.1016/j.mcpdig.2025.100241","url":null,"abstract":"<div><h3>Objective</h3><div>To develop and validate an artificial intelligence–powered platform that simulates surgical oral examinations, addressing the limitations of traditional faculty-led sessions.</div></div><div><h3>Patients and Methods</h3><div>This cross-sectional study, conducted from June 1, 2024, through December 1, 2024, comprised technical validation and educational assessment of a novel large language model (LLM)–based surgical education tool (surgery oral examination large language model [SOE-LLM]). The study involved 12 surgical clerkship students completing their core rotation at a major academic medical center. The SOE-LLM, using MIMIC-IV–derived surgical cases (acute appendicitis and pancreatitis), was implemented to simulate oral examinations. Technical validation assessed performance across 8 domains: case presentation accuracy, physical examination findings, historical detail preservation, laboratory data reporting, imaging interpretation, management decisions, and recognition of contraindicated interventions. Educational utility was evaluated using a 5-point Likert scale.</div></div><div><h3>Results</h3><div>Technical validation showed the SOE-LLM’s ability to function as a consistent oral examiner. The model accurately guided students through case presentations, responded to diagnostic questions, and provided clinically sound responses based on MIMIC-IV cases. When tested with standardized prompts, it maintained examination fidelity, requiring proper diagnostic reasoning and differentiating operative versus medical management. Student evaluations highlighted the platform’s value as an examination preparation tool (mean, 4.250; SEM, 0.1794) and its ability to create a low-stakes environment for high-stakes decision practice (mean, 4.833; SEM, 0.1124).</div></div><div><h3>Conclusion</h3><div>The SOE-LLM shows potential as a valuable tool for surgical education, offering a consistent and accessible platform for simulating oral examinations.</div></div>","PeriodicalId":74127,"journal":{"name":"Mayo Clinic Proceedings. Digital health","volume":"3 3","pages":"Article 100241"},"PeriodicalIF":0.0,"publicationDate":"2025-06-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144522419","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Real-World Smartphone Data Predicts Mood After Ischemic Stroke and Transient Ischemic Attack Symptoms and May Constitute Digital Endpoints: A Proof-of-Concept Study","authors":"Stephanie Zawada PhD, MS ,&nbsp;Jestrii Acosta MS ,&nbsp;Caden Collins BA ,&nbsp;Oana Dumitrascu MD, MS ,&nbsp;Ehab Harahsheh MBBS ,&nbsp;Clinton Hagen MS ,&nbsp;Ali Ganjizadeh MD ,&nbsp;Elham Mahmoudi MD ,&nbsp;Bradley Erickson MD, PhD ,&nbsp;Bart Demaerschalk MD, MSc","doi":"10.1016/j.mcpdig.2025.100240","DOIUrl":"10.1016/j.mcpdig.2025.100240","url":null,"abstract":"<div><h3>Objective</h3><div>To assess the feasibility of using smartphones to longitudinally collect objective behavior measures and establish the extent to which they can predict gold-standard depression severity in patients with ischemic stroke and transient ischemic attack (IS/TIA) symptoms.</div></div><div><h3>Patients and Methods</h3><div>Participants with IS/TIA symptoms were monitored in real-world settings using the Beiwe application for 8 or more weeks during March 1, 2024 to November 15, 2024. Depression symptoms were tracked via weekly Patient Health Questionnaire (PHQ)-8 surveys, monthly personnel-administered Montgomery–Åsberg Depression Rating Scale (MADRS) assessments, and weekly averages of smartphone sensor measures. Repeated measures correlation established associations between PHQ-8 scores and objective behavior measures. To investigate how closely smartphone data predicted MADRS scores, linear mixed models were used.</div></div><div><h3>Results</h3><div>Among enrolled participants (n=54), 35 completed the study (64.8%). PHQ-8 scores were associated with distance from home (<em>r</em>=0.173), time spent at home (<em>r</em>=−0.147) and PHQ-8 administration duration (<em>r</em>=0.151). Using demographic data and the most recent PHQ-8 scores, average root-mean-squared error for depression severity prediction across models was 1.64 with only PHQ-8 scores, 1.49 also including accelerometer and GPS data, and 1.36 also including PHQ-8 administration duration.</div></div><div><h3>Conclusion</h3><div>Smartphone sensors captured objective behavior measures in patients with IS/TIA. In predictive models, the accuracy of depression severity scores improved as measures from additional smartphone sensors were included. Future research should validate this decentralized, exploratory approach in a larger cohort. Our work is a step toward showing that real-world monitoring with active and passive data may triage patients with IS/TIA for efficient depression screening and provide digital mobility and response time endpoints.</div></div>","PeriodicalId":74127,"journal":{"name":"Mayo Clinic Proceedings. Digital health","volume":"3 3","pages":"Article 100240"},"PeriodicalIF":0.0,"publicationDate":"2025-06-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144596839","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Digital Technology for Informed Choices at Childbirth in Brazil: A Randomized Controlled Trial","authors":"Carmen Simone Grilo Diniz PhD ,&nbsp;Ana Carolina Arruda Franzon PhD ,&nbsp;Beatriz Fioretti-Foschi PhD ,&nbsp;Livia Sanches Pedrilio MSc ,&nbsp;Edson Amaro Jr. PhD ,&nbsp;João Ricardo Sato PhD ,&nbsp;Denise Yoshie Niy PhD","doi":"10.1016/j.mcpdig.2025.100238","DOIUrl":"10.1016/j.mcpdig.2025.100238","url":null,"abstract":"<div><h3>Objective</h3><div>To design and evaluate an information and communication intervention via a smartphone application that provides access to essential information on best practices and safety in maternity services.</div></div><div><h3>Participants and Methods</h3><div>A randomized controlled trial using a mobile application to recruit and deliver the intervention, conducted from October 31, 2020, through December 12, 2020. The study was offered to all users registered on the application who self-identified as women, with ages between 18 and 49 years, with at least 1 child, pregnant or interested in having children in the future. The primary outcome measured was increased participant engagement in seeking an active role and informed choices. Participants received information about best practices (intervention) or about diapers (control). The trial was registered on the Brazilian Clinical Trials Registry Platform, and the protocol was published according to CONSORT e-Health guidelines. Effect size was estimated by odds ratio, with CI and <em>P</em> values.</div></div><div><h3>Results</h3><div>In total, 20,608 users were invited to participate in the study; of 17,643 enrolled (85.6% of invited users), 13,969 (79.1% of enrolled participants) women completed the intervention stage and were included in the analyses; 7121 (50.9% of all women included) had up to high school level; and 5855 (41.9%) used both public and private services. The intervention group registered an increased engagement in seeking an active role or making informed choices (odds ratio, 2.06; <em>P</em>&lt;.001). The intervention proved to be highly effective for all secondary outcomes, as well.</div></div><div><h3>Conclusion</h3><div>This affordable digital technology effectively promoted awareness of safer, empowered choices in childbirth care, facilitating the translation of evidence-based, rights-based knowledge from institutional guidelines and recommendations to a broader audience.</div></div><div><h3>Trial Registration</h3><div>Brazilian Registry of Clinical Trials Identifier: RBR-3g5f9f; WHO’s Unique Trial Identifier: UTN U1111-1255-8683.</div></div>","PeriodicalId":74127,"journal":{"name":"Mayo Clinic Proceedings. Digital health","volume":"3 3","pages":"Article 100238"},"PeriodicalIF":0.0,"publicationDate":"2025-06-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144534515","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Racial and Ethnic Representation and Study Engagement in a Siteless Digital Clinical Trial Using a Smartwatch: Findings From the Apple Heart Study","authors":"Kaylin T. Nguyen MD ,&nbsp;Jingzhi Yu BA ,&nbsp;Haley Hedlin PhD ,&nbsp;Adam T. Phillips MD ,&nbsp;Sumbul Desai MD ,&nbsp;Lauren Cheung MD ,&nbsp;Peter R. Kowey MD ,&nbsp;Sneha S. Jain MD ,&nbsp;John S. Rumsfeld MD, PhD ,&nbsp;Andrea M. Russo MD ,&nbsp;Christopher B. Granger MD ,&nbsp;Mellanie True Hills BS ,&nbsp;Manisha Desai PhD ,&nbsp;Kenneth W. Mahaffey MD ,&nbsp;Mintu P. Turakhia MD, MAS ,&nbsp;Marco V. Perez MD","doi":"10.1016/j.mcpdig.2025.100232","DOIUrl":"10.1016/j.mcpdig.2025.100232","url":null,"abstract":"<div><h3>Objective</h3><div>To evaluate differences in study engagement in diverse racial/ethnic groups that have been significantly underrepresented in atrial fibrillation and digital clinical trials.</div></div><div><h3>Patients and Methods</h3><div>This was a secondary analysis of participants from the Apple Heart Study, a prospective, siteless, single-arm pragmatic clinical trial from November 29, 2017, to January 31, 2019. Black, Hispanic, Asian, and White participants were monitored using an irregular rhythm notification algorithm designed to detect atrial fibrillation on a smartwatch. Logistic regression was performed to evaluate the relationship between race/ethnicity and completion of the first study visit after an irregular rhythm notification, adjusting for demographic characteristics and comorbidities.</div></div><div><h3>Results</h3><div>Of the 419,297 participants, 393,396 (93.8%) individuals self-identified as White, Black, Hispanic, or Asian. Overall, participants were 57% men and had a mean (SD) age of 41 (13) years. Among 2044 (0.52%) participants who received an irregular rhythm notification, non-White participants had lower odds of completing the initial virtual study visit compared with White participants (Black: OR, 0.61; 95% CI, 0.39-0.94; Hispanic: OR, 0.62; 95% CI, 0.40-0.95; Asian: OR, 0.40; 95% CI, 0.23-0.66) after multivariate adjustment. Among those who completed the initial study visit, there was no statistically significant difference in the odds of returning the electrocardiogram patch in the non-White groups compared with that of the White group.</div></div><div><h3>Conclusion</h3><div>Despite successful recruitment of racially and ethnically diverse participants, there were differences in subsequent engagement by non-White compared with that by White participants. Equitable representation and engagement of diverse racial and ethnic groups in digital clinical studies requires further study.</div></div><div><h3>Trial Registration</h3><div>Clinicaltrials.gov Identifier: <span><span>NCT03335800</span><svg><path></path></svg></span></div></div>","PeriodicalId":74127,"journal":{"name":"Mayo Clinic Proceedings. Digital health","volume":"3 3","pages":"Article 100232"},"PeriodicalIF":0.0,"publicationDate":"2025-06-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144365990","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Erratum to “Assessment of Positive Cardiac Remodeling in Hypertrophic Obstructive Cardiomyopathy Using an Artificial Intelligence-Based Electrocardiographic Platform in Patients Treated With Mavacamten”","authors":"","doi":"10.1016/j.mcpdig.2025.100209","DOIUrl":"10.1016/j.mcpdig.2025.100209","url":null,"abstract":"","PeriodicalId":74127,"journal":{"name":"Mayo Clinic Proceedings. Digital health","volume":"3 3","pages":"Article 100209"},"PeriodicalIF":0.0,"publicationDate":"2025-06-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144280103","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"What Becomes of the Human Touch in the Age of Generative Artificial Intelligence?","authors":"Kishwen Kanna Yoga Ratnam MD, MPH, DrPH","doi":"10.1016/j.mcpdig.2025.100226","DOIUrl":"10.1016/j.mcpdig.2025.100226","url":null,"abstract":"","PeriodicalId":74127,"journal":{"name":"Mayo Clinic Proceedings. Digital health","volume":"3 2","pages":"Article 100226"},"PeriodicalIF":0.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144184999","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"United States Food and Drug Administration Regulation of Clinical Software in the Era of Artificial Intelligence and Machine Learning","authors":"Vidhi Singh BS,&nbsp;Susan Cheng MD, MPH,&nbsp;Alan C. Kwan MD, MS,&nbsp;Joseph Ebinger MD, MS","doi":"10.1016/j.mcpdig.2025.100231","DOIUrl":"10.1016/j.mcpdig.2025.100231","url":null,"abstract":"","PeriodicalId":74127,"journal":{"name":"Mayo Clinic Proceedings. Digital health","volume":"3 3","pages":"Article 100231"},"PeriodicalIF":0.0,"publicationDate":"2025-05-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144470263","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}